← Back to headlines
Jazz Pharmaceuticals Prices $1.1 Billion Exchangeable Notes Offering
Jazz Pharmaceuticals has successfully priced a $1.1 billion offering of exchangeable notes, increasing the size of the original private debt placement. The financing will support the company’s ongoing capital requirements and strategic initiatives.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
Coverage Timeline
First report: investing-com · 27 Aug, 04:36|Full coverage: 2 · 4h|Window: 4h
Left-leaningCenterRight-leaning
